デフォルト表紙
市場調査レポート
商品コード
1789864

注射器の市場規模、シェア、動向分析レポート:使用方法別、デザイン別、用途別、素材別、最終用途別、地域別、セグメント別予測、2025年~2033年

Syringes Market Size, Share & Trends Analysis Report By Usage, By Design, By Application, By Material, By End Use, By Region And Segment Forecasts, By Region, And Segment Forecasts, 2025 - 2033


出版日
ページ情報
英文 110 Pages
納期
2~10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.50円
注射器の市場規模、シェア、動向分析レポート:使用方法別、デザイン別、用途別、素材別、最終用途別、地域別、セグメント別予測、2025年~2033年
出版日: 2025年07月29日
発行: Grand View Research
ページ情報: 英文 110 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

注射器市場のサマリー

世界の注射器市場規模は2024年に170億3,000万米ドルと推計され、2033年には356億1,000万米ドルに達すると予測され、2025年から2033年までのCAGRは8.66%で成長します。注射器の需要は、慢性疾患の負担の増加、外科手術の件数の増加、入院の増加によって高まっています。

さらに、注射器の進歩が市場成長を促進すると予測されています。慢性疾患の蔓延とそれに伴う入院の増加は主要な市場促進要因です。WHOが2024年12月に発表したデータによると、慢性疾患は2021年に世界で少なくとも4,300万人の命を奪いました。また、メイヨークリニックが2024年2月に発表した研究では、慢性疾患の世界の経済的負担は2030年までに推定47兆米ドルに達すると予測しています。このような負担の増大は、ヘルスケアシステムがこれらの長期疾患の管理・治療に取り組む中で、注射器を含む医療用品に対する需要が高まっていることを浮き彫りにしています。

さらに、入院患者数の増加や外科手術件数の増加が、今後数年間の注射器需要の原動力となります。美容整形手術、心臓手術、整形外科手術などの外科手術がさまざまな国や地域で普及するにつれて、注射器のニーズは高まっています。これらの手術では、麻酔や投薬のために注射器の使用が必要となることが多く、全体的な需要の急増に寄与しています。さらに、手術手技の進歩や患者数の増加が、ヘルスケア現場における注射器ニーズの高まりを後押ししています。

安全性が重視されるようになり、シリンジが自動で取り外し可能になったことで、今後数年間は市場の成長が促進されると予想されます。各社は、こうした先進的なソリューションで提供する製品の技術革新をますます進めています。例えば、2024年3月、Hindusta Syringes and Medical Devices社は、安全針付き使い捨て注射器Dispojektを発表しました。これらの注射器は、医療従事者の偶発的な針刺し損傷(NSI)のリスクを低減し、感染管理コストを削減し、廃棄やトレーニングに関連する費用を最小限に抑え、最終的に医療部門に長期的な財務上の利益をもたらすことを目的としています。

さらに、予防接種やワクチン接種の需要の高まりが注射器の必要性を高めており、新規参入企業はこの需要に対応するため、自動針刺し防止注射器の製造に注力しています。例えば、VaccinesWorkが2024年2月に発表したデータによると、リバイタルヘルスケアは、WHOが事前認定した単回使用の安全な注射器を製造するアフリカ初のメーカーとなりました。これらのアフリカ製自動無効化(AD)注射器は、アフリカ大陸全域での予防接種活動を強化しています。ケニアでは、予防接種システムがAD注射器の使用を強く推奨しています。AD注射器は、1回の注射後に自動的にロックされ、再使用を防止するように開発されており、予防接種の安全性のゴールドスタンダードとなっています。

「注射器の平均輸送時間は、ケニア大陸で最大80~90%短縮される見込みです」。リバイタル・ヘルスケア(EPZ)リミテッドのロニーク・R・ヴォラ取締役は言います。

「インドが注射器生産大国であるにもかかわらず、私たちはこの注射器をインドや欧州4カ国、その他のアフリカ諸国を含む35カ国以上に輸出し、障壁を打ち破りました。ケニア保健省のマラリア撲滅評議会&基金の創設メンバーでもあるヴォラは言います。

このような予防接種用注射器の製造・輸出の増加は、今後数年間の市場成長を促進すると予想されます。

本レポートの参考資料として、無料サンプル版をご請求ください。

さらに、様々なサイズの注射器が入手可能であることも市場の成長を支えています。以下の図解は、2022年と2023年のいくつかの自動無効化注射器の価格をサイズとブランド名とともにハイライトしています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 注射器市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 注射器市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 注射器市場:使用方法別の推定・動向分析

  • セグメントダッシュボード
  • 世界の注射器市場の使用方法別変動分析
  • 世界の注射器市場規模と動向分析(使用方法別、2021~2033年)
  • 使い捨て注射器
  • 再利用可能な注射器

第5章 注射器市場:デザイン別の推定・動向分析

  • セグメントダッシュボード
  • 世界の注射器市場のデザイン別変動分析
  • 世界の注射器市場規模と動向分析(デザイン別、2021~2033年)
  • 従来の注射器
  • 安全注射器
  • プレフィルドシリンジ(PFS)
  • スマートシリンジ

第6章 注射器市場:用途別の推定・動向分析

  • セグメントダッシュボード
  • 世界の注射器市場の用途別変動分析
  • 世界の注射器市場規模と動向分析(用途別、2021~2033年)
  • ワクチンと予防接種
  • アナフィラキシー
  • 関節リウマチ
  • 糖尿病
  • 自己免疫疾患
  • 腫瘍学
  • その他

第7章 注射器市場:素材別の推定・動向分析

  • セグメントダッシュボード
  • 世界の注射器市場の素材別変動分析
  • 世界の注射器市場規模と動向分析(素材別、2021~2033年)
  • プラスチック注射器
  • ガラス注射器

第8章 注射器市場:最終用途別の推定・動向分析

  • セグメントダッシュボード
  • 世界の注射器市場の最終用途別変動分析
  • 世界の注射器市場規模と動向分析(最終用途別、2021~2033年)
  • 直接入札
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第9章 注射器市場:地域推定・動向分析(デザイン別、使用方法別、用途別、素材別、最終用途別)

  • 地域ダッシュボード
  • 市場規模と予測および動向分析、2021~2033年
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • インド
    • 中国
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第10章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
    • イノベーター
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • Key customers
    • Global Key company market share analysis, 2024
    • Revital
    • Hindustan Syringes &Medical Devices Ltd
    • Wuxi Yushou Medical Appliances Co., Ltd
    • Nipro Europe Group Companies
    • Abu Dhabi Medical Devices Company
    • B. Braun SE
    • BD
    • Sharps Technology, Inc.
    • Cardinal Health
    • Vita Needle Company
    • Terumo Europe NV
    • Taisei Kako Ltd
    • ulti med Products
    • Henke Sass Wolf GmbH
    • ITO CORPORATION
    • Retractable Technologies, Inc.
    • kohope.com
    • Al Shifa Medical Products Co
    • Liaoning Kangyi Medical Equipment Co., Ltd
    • CANE SPA
    • SMB Corporation of India
    • Lifelong Meditech Private Limited.
    • OSAKA CHEMICAL Co., Ltd
    • JMS Co.Ltd
    • APEX MEDICAL DEVICES
    • Cartel Health Care Pvt. Ltd
    • VEM Tooling Co., Ltd.(VEM Thailand Co., Ltd.)
    • Fresenius Kabi Canada Ltd
    • ICU Medical, Inc.
  • ヒートマップ分析/企業市況分析
  • 2024年の企業市場シェア予測分析
  • その他の主要市場企業のリスト
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. North America syringes market, by country, 2021 - 2033 (USD Million)
  • Table 4. North America syringes market, by design, 2021 - 2033 (USD Million)
  • Table 5. North America syringes market, by material, 2021 - 2033 (USD Million)
  • Table 6. North America syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 7. North America syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 8. North America syringes market, by application, 2021 - 2033 (USD Million)
  • Table 9. U.S. syringes market, by design, 2021 - 2033 (USD Million)
  • Table 10. U.S. syringes market, by material, 2021 - 2033 (USD Million)
  • Table 11. U.S. syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 12. U.S. syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 13. U.S. syringes market, by application, 2021 - 2033 (USD Million)
  • Table 14. Canada syringes market, by design, 2021 - 2033 (USD Million)
  • Table 15. Canada syringes market, by material, 2021 - 2033 (USD Million)
  • Table 16. Canada syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 17. Canada syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 18. Canada syringes market, by application, 2021 - 2033 (USD Million)
  • Table 19. Mexico syringes market, by design, 2021 - 2033 (USD Million)
  • Table 20. Mexico syringes market, by material, 2021 - 2033 (USD Million)
  • Table 21. Mexico syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 22. Mexico syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 23. Mexico syringes market, by application, 2021 - 2033 (USD Million)
  • Table 24. Europe syringes market, by country, 2021 - 2033 (USD Million)
  • Table 25. Europe syringes market, by material, 2021 - 2033 (USD Million)
  • Table 26. Europe syringes market, by design, 2021 - 2033 (USD Million)
  • Table 27. Europe syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 28. Europe syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 29. Europe syringes market, by application, 2021 - 2033 (USD Million)
  • Table 30. UK syringes market, by design, 2021 - 2033 (USD Million)
  • Table 31. UK syringes market, by material, 2021 - 2033 (USD Million)
  • Table 32. UK syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 33. UK syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 34. UK syringes market, by application, 2021 - 2033 (USD Million)
  • Table 35. Germany syringes market, by design, 2021 - 2033 (USD Million)
  • Table 36. Germany syringes market, by material, 2021 - 2033 (USD Million)
  • Table 37. Germany syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 38. Germany syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 39. Germany syringes market, by application, 2021 - 2033 (USD Million)
  • Table 40. France syringes market, by design, 2021 - 2033 (USD Million)
  • Table 41. France syringes market, by material, 2021 - 2033 (USD Million)
  • Table 42. France syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 43. France syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 44. France syringes market, by application, 2021 - 2033 (USD Million)
  • Table 45. Italy syringes market, by design, 2021 - 2033 (USD Million)
  • Table 46. Italy syringes market, by material, 2021 - 2033 (USD Million)
  • Table 47. Italy syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 48. Italy syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 49. Italy syringes market, by application, 2021 - 2033 (USD Million)
  • Table 50. Spain syringes market, by design, 2021 - 2033 (USD Million)
  • Table 51. Spain syringes market, by material, 2021 - 2033 (USD Million)
  • Table 52. Spain syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 53. Spain syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 54. Spain syringes market, by application, 2021 - 2033 (USD Million)
  • Table 55. Denmark syringes market, by design, 2021 - 2033 (USD Million)
  • Table 56. Denmark syringes market, by material, 2021 - 2033 (USD Million)
  • Table 57. Denmark syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 58. Denmark syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 59. Denmark syringes market, by application, 2021 - 2033 (USD Million)
  • Table 60. Sweden syringes market, by design, 2021 - 2033 (USD Million)
  • Table 61. Sweden syringes market, by material, 2021 - 2033 (USD Million)
  • Table 62. Sweden syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 63. Sweden syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 64. Sweden syringes market, by application, 2021 - 2033 (USD Million)
  • Table 65. Norway syringes market, by design, 2021 - 2033 (USD Million)
  • Table 66. Norway syringes market, by material, 2021 - 2033 (USD Million)
  • Table 67. Norway syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 68. Norway syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 69. Norway syringes market, by application, 2021 - 2033 (USD Million)
  • Table 70. Asia Pacific syringes market, by country, 2021 - 2033 (USD Million)
  • Table 71. Asia Pacific syringes market, by material, 2021 - 2033 (USD Million)
  • Table 72. Asia Pacific syringes market, by design, 2021 - 2033 (USD Million)
  • Table 73. Asia Pacific syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 74. Asia Pacific syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 75. Asia Pacific syringes market, by application, 2021 - 2033 (USD Million)
  • Table 76. China syringes market, by design, 2021 - 2033 (USD Million)
  • Table 77. China syringes market, by material, 2021 - 2033 (USD Million)
  • Table 78. China syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 79. China syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 80. China syringes market, by application, 2021 - 2033 (USD Million)
  • Table 81. Japan syringes market, by design, 2021 - 2033 (USD Million)
  • Table 82. Japan syringes market, by material, 2021 - 2033 (USD Million)
  • Table 83. Japan syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 84. Japan syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 85. Japan syringes market, by application, 2021 - 2033 (USD Million)
  • Table 86. India syringes market, by design, 2021 - 2033 (USD Million)
  • Table 87. India syringes market, by material, 2021 - 2033 (USD Million)
  • Table 88. India syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 89. India syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 90. India syringes market, by application, 2021 - 2033 (USD Million)
  • Table 91. South Korea syringes market, by design, 2021 - 2033 (USD Million)
  • Table 92. South Korea syringes market, by material, 2021 - 2033 (USD Million)
  • Table 93. South Korea syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 94. South Korea syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 95. South Korea syringes market, by application, 2021 - 2033 (USD Million)
  • Table 96. Australia syringes market, by design, 2021 - 2033 (USD Million)
  • Table 97. Australia syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 98. Australia syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 99. Australia syringes market, by application, 2021 - 2033 (USD Million)
  • Table 100. Thailand syringes market, by design, 2021 - 2033 (USD Million)
  • Table 101. Thailand syringes market, by material, 2021 - 2033 (USD Million)
  • Table 102. Thailand syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 103. Thailand syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 104. Thailand syringes market, by application, 2021 - 2033 (USD Million)
  • Table 105. Latin America syringes market, by country, 2021 - 2033 (USD Million)
  • Table 106. Latin America syringes market, by material, 2021 - 2033 (USD Million)
  • Table 107. Latin America syringes market, by design, 2021 - 2033 (USD Million)
  • Table 108. Latin America syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 109. Latin America syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 110. Latin America syringes market, by application, 2021 - 2033 (USD Million)
  • Table 111. Brazil syringes market, by design, 2021 - 2033 (USD Million)
  • Table 112. Brazil syringes market, by material, 2021 - 2033 (USD Million)
  • Table 113. Brazil syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 114. Brazil syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 115. Brazil syringes market, by application, 2021 - 2033 (USD Million)
  • Table 116. Argentina syringes market, by design, 2021 - 2033 (USD Million)
  • Table 117. Argentina syringes market, by material, 2021 - 2033 (USD Million)
  • Table 118. Argentina syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 119. Argentina syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 120. Argentina syringes market, by application, 2021 - 2033 (USD Million)
  • Table 121. Middle East & Africa syringes market, by country, 2021 - 2033 (USD Million)
  • Table 122. Middle East & Africa syringes market, by material, 2021 - 2033 (USD Million)
  • Table 123. Middle East & Africa syringes market, by design, 2021 - 2033 (USD Million)
  • Table 124. Middle East & Africa syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 125. Middle East & Africa syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 126. Middle East & Africa syringes market, by application, 2021 - 2033 (USD Million)
  • Table 127. South Africa syringes market, by design, 2021 - 2033 (USD Million)
  • Table 128. South Africa syringes market, by material, 2021 - 2033 (USD Million)
  • Table 129. South Africa syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 130. South Africa syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 131. South Africa syringes market, by application, 2021 - 2033 (USD Million)
  • Table 132. Saudi Arabia syringes market, by design, 2021 - 2033 (USD Million)
  • Table 133. Saudi Arabia syringes market, by material, 2021 - 2033 (USD Million)
  • Table 134. Saudi Arabia syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 135. Saudi Arabia syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 136. Saudi Arabia syringes market, by application, 2021 - 2033 (USD Million)
  • Table 137. UAE syringes market, by design, 2021 - 2033 (USD Million)
  • Table 138. UAE syringes market, by material, 2021 - 2033 (USD Million)
  • Table 139. UAE syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 140. UAE syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 141. UAE syringes market, by application, 2021 - 2033 (USD Million)
  • Table 142. Kuwait syringes market, by design, 2021 - 2033 (USD Million)
  • Table 143. Kuwait syringes market, by material, 2021 - 2033 (USD Million)
  • Table 144. Kuwait syringes market, by usage, 2021 - 2033 (USD Million)
  • Table 145. Kuwait syringes market, by end use, 2021 - 2033 (USD Million)
  • Table 146. Kuwait syringes market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Syringes Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Syringes Market, for Usage, 2021 - 2033 (USD Million)
  • Fig. 15 Syringes Market, for Disposable Syringes, 2021 - 2033 (USD Million)
  • Fig. 16 Syringes Market, for Reusable Syringes, 2021 - 2033 (USD Million)
  • Fig. 17 Syringes Market, for Design, 2021 - 2033 (USD Million)
  • Fig. 18 Syringes Market, for Conventional Syringes, 2021 - 2033 (USD Million)
  • Fig. 19 Syringes Market, for Safety Syringes, 2021 - 2033 (USD Million)
  • Fig. 20 Syringes Market, for Retractable Safety Syringes, 2021 - 2033 (USD Million)
  • Fig. 21 Syringes Market, for Non-Retractable Safety Syringes, 2021 - 2033 (USD Million)
  • Fig. 22 Syringes Market, for Prefilled Syringes (PFS), 2021 - 2033 (USD Million)
  • Fig. 23 Syringes Market, for Smart Syringes, 2021 - 2033 (USD Million)
  • Fig. 24 Syringes Market, for Material, 2021 - 2033 (USD Million)
  • Fig. 25 Syringes Market, for Plastic Syringes, 2021 - 2033 (USD Million)
  • Fig. 26 Syringes Market, for Glass Syringes, 2021 - 2033 (USD Million)
  • Fig. 27 Syringes Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 28 Syringes Market, for Vaccines and Immunizations, 2021 - 2033 (USD Million)
  • Fig. 29 Syringes Market, for Anaphylaxis, 2021 - 2033 (USD Million)
  • Fig. 30 Syringes Market, for Rheumatoid Arthritis, 2021 - 2033 (USD Million)
  • Fig. 31 Syringes Market, for Diabetes, 2021 - 2033 (USD Million)
  • Fig. 32 Syringes Market, for Autoimmune Diseases, 2021 - 2033 (USD Million)
  • Fig. 33 Syringes Market, for Oncology, 2021 - 2033 (USD Million)
  • Fig. 34 Syringes Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 35 Syringes Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 36 Syringes Market, for Direct Tenders, 2021 - 2033 (USD Million)
  • Fig. 37 Syringes Market, for Hospital Pharmacies, 2021 - 2033 (USD Million)
  • Fig. 38 Syringes Market, for Retail Pharmacies, 2021 - 2033 (USD Million)
  • Fig. 39 Syringes Market, for Online Pharmacies, 2021 - 2033 (USD Million)
  • Fig. 40 Regional Outlook, 2024 & 2033
  • Fig. 41 North America Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 43 Canada Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 44 Mexico Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 45 Europe Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 46 Germany Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 47 UK Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 48 France Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 49 Italy Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 50 Spain Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 52 Sweden Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 53 Norway Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 54 Asia Pacific Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 55 Japan Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 56 China Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 57 India Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 58 Australia Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 59 South Korea Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 60 Thailand Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 61 Latin America Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 62 Brazil Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 63 Argentina Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 64 Middle East and Africa Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 65 South Africa Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 66 Saudi Arabia Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 67 UAE Syringes Market, 2021 - 2033 (USD Million)
  • Fig. 68 Kuwait Syringes Market, 2021 - 2033 (USD Million)
目次
Product Code: GVR-4-68038-077-4

Syringes Market Summary

The global syringes market size was estimated at USD 17.03 billion in 2024 and is projected to reach USD 35.61 billion by 2033, growing at a CAGR of 8.66% from 2025 to 2033. The demand for syringes is rising owing to the increasing burden of chronic disorders, the rising number of surgical procedures, and the growing hospitalizations.

In addition, the advancements in syringes are anticipated to propel the market growth. The increasing prevalence of chronic diseases and the resulting hospitalizations are major market drivers. According to the data published by the WHO in December 2024, chronic diseases claimed the lives of at least 43 million people globally in 2021. In addition, a study published by the Mayo Clinic in February 2024 projects that the global economic burden of chronic diseases will reach an estimated USD 47 trillion by 2030. This growing burden underscores the rising demand for medical supplies, including syringes, as healthcare systems work to manage and treat these long-term conditions.

Furthermore, the rising number of hospitalizations and an increasing volume of surgical procedures drive the demand for syringes in the coming years. As surgical interventions, including cosmetic, cardiac, and orthopedic surgeries, become more prevalent across various countries and regions, the need for syringes grows. These surgeries often require the use of syringes for anesthesia and medication delivery, contributing to the overall surge in demand. Moreover, advancements in surgical techniques and a growing patient population further support this rising need for syringes in healthcare settings.

The growing emphasis on safety and auto-disable syringes is expected to propel market growth in the coming years. Companies are increasingly innovating their product offerings with these advanced solutions. For example, in March 2024, Hindusta Syringes and Medical Devices introduced the Dispojekt single-use syringes with safety needles. These syringes aim to reduce the risk of accidental needle-stick injuries (NSIs) among healthcare workers, lower infection control costs, and minimize expenses related to disposal and training, ultimately delivering long-term financial benefits to the healthcare sector.

Moreover, the growing demand for vaccinations and immunizations is driving the need for syringes, with new market entrants focusing on manufacturing auto-disable syringes to meet this demand. For example, according to data published by VaccinesWork in February 2024, Revital Healthcare has become the first African manufacturer of WHO-prequalified, single-use, safe syringes. These African-made auto-disable (AD) syringes enhance immunization efforts across the continent. In Kenya, the immunization system strongly advocates for AD syringes, which are developed to prevent reuse by locking automatically post single injection, making them the gold standard for vaccination safety.

"Average syringe transport times are expected to decrease by up to 80-90% on the continent". Said Roneek R. Vora, director, Revital Healthcare (EPZ) Limited

"We broke barriers by exporting these syringes to more than 35 countries, including India - despite India being a syringe production powerhouse -and four European countries, and to other African countries." Says Vora, who is also a founding member of the Kenyan Ministry of Health's End Malaria Council & Fund.

Such increasing manufacturing and export of auto-disabled syringes for vaccinations and immunizations is anticipated to propel market growth in the coming years.

To learn more about this report, request a free sample copy

In addition, the availability of syringes in various sizes supports market growth. The pictorial representation below highlights the prices of some auto-disabled syringes along with their size and brand name for 2022 and 2023.

Global Syringes Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global syringes market report based on design, usage, application, material, end use, and region:

  • Usage Outlook (Revenue, USD Million, 2021 - 2033)
  • Disposable Syringes
  • Reusable Syringes
  • Design Outlook (Revenue, USD Million, 2021 - 2033)
  • Conventional Syringes
  • Safety Syringes
    • Retractable Safety Syringes
    • Non-Retractable Safety Syringes
  • Prefilled Syringes (PFS)
  • Smart Syringes
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Vaccines and Immunizations
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Autoimmune Diseases
  • Oncology
  • Others
  • Material Outlook (Revenue, USD Million, 2021 - 2033)
  • Plastic Syringes
  • Glass Syringes
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Direct Tenders
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Design
    • 1.1.2. Usage
    • 1.1.3. Application
    • 1.1.4. Material
    • 1.1.5. End-use
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Syringes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for vaccination and immunization
      • 3.2.1.2. Rising adoption of safety and prefilled syringes
      • 3.2.1.3. Increasing disease burden
      • 3.2.1.4. Technological advancements
      • 3.2.1.5. Rising production capacities for syringes
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Recalls of syringes
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Growing number of clinical trials
      • 3.2.3.2. Increasing development of auto-disable syringes
      • 3.2.3.3. Growth potential in emerging economies in syringes market
      • 3.2.3.4. Rising distribution partnerships
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Potential complications and risks associated with syringes
  • 3.3. Syringes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Syringes Market: Usage Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Syringes Market Usage Movement Analysis
  • 4.3. Global Syringes Market Size & Trend Analysis, by Usage, 2021 to 2033 (USD Million)
  • 4.4. Disposable Syringes
    • 4.4.1. Disposable syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Reusable Syringes
    • 4.5.1. Reusable syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Syringes Market: Design Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Syringes Market Design Movement Analysis
  • 5.3. Global Syringes Market Size & Trend Analysis, by Design, 2021 to 2033 (USD Million)
  • 5.4. Conventional Syringes
    • 5.4.1. Conventional syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Safety Syringes
    • 5.5.1. Safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.1. Retractable Safety Syringes
        • 5.5.1.1.1. Retractable safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.2. Non-retractable Safety Syringes
        • 5.5.1.2.1. Non-retractable safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Prefilled Syringes (PFS)
    • 5.6.1. Prefilled syringes (PFS) market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Smart Syringes
    • 5.7.1. Smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Syringes Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Syringes Market Application Movement Analysis
  • 6.3. Global Syringes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Vaccines and Immunizations
    • 6.4.1. Vaccines and immunizations market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Anaphylaxis
    • 6.5.1. Anaphylaxis market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Rheumatoid Arthritis
    • 6.6.1. Rheumatoid arthritis market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Diabetes
    • 6.7.1. Diabetes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.8. Autoimmune Diseases
    • 6.8.1. Autoimmune diseases market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.9. Oncology
    • 6.9.1. Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.10. Others
    • 6.10.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Syringes Market: Material Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Syringes Market Material Movement Analysis
  • 7.3. Global Syringes Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
  • 7.4. Plastic Syringes
    • 7.4.1. Plastic syringes market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Glass Syringes
    • 7.5.1. Glass syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Syringes Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Syringes Market End Use Movement Analysis
  • 8.3. Global Syringes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.4. Direct Tenders
    • 8.4.1. Direct tenders market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Hospital Pharmacies
    • 8.5.1. Hospital pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Retail Pharmacies
    • 8.6.1. Retail pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Online Pharmacies
    • 8.7.1. Retail pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Syringes Market: Regional Estimates & Trend Analysis By Design, By Usage, By Application, By Material, By End Use

  • 9.1. Regional Dashboard
  • 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 9.3. North America
    • 9.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Competitive scenario
      • 9.3.2.3. Regulatory framework
      • 9.3.2.4. Reimbursement scenario
      • 9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Competitive scenario
      • 9.3.3.3. Regulatory framework
      • 9.3.3.4. Reimbursement scenario
      • 9.3.3.5. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key country dynamics
      • 9.3.4.2. Competitive scenario
      • 9.3.4.3. Regulatory framework
      • 9.3.4.4. Reimbursement scenario
      • 9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Competitive scenario
      • 9.4.1.3. Regulatory framework
      • 9.4.1.4. Reimbursement scenario
      • 9.4.1.5. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Competitive scenario
      • 9.4.2.3. Regulatory framework
      • 9.4.2.4. Reimbursement scenario
      • 9.4.2.5. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Competitive scenario
      • 9.4.3.3. Regulatory framework
      • 9.4.3.4. Reimbursement scenario
      • 9.4.3.5. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Competitive scenario
      • 9.4.4.3. Regulatory framework
      • 9.4.4.4. Reimbursement scenario
      • 9.4.4.5. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Competitive scenario
      • 9.4.5.3. Regulatory framework
      • 9.4.5.4. Reimbursement scenario
      • 9.4.5.5. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.6. Denmark
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Competitive scenario
      • 9.4.6.3. Regulatory framework
      • 9.4.6.4. Reimbursement scenario
      • 9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Competitive scenario
      • 9.4.7.3. Regulatory framework
      • 9.4.7.4. Reimbursement scenario
      • 9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.4.8. Norway
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Competitive scenario
      • 9.4.8.3. Regulatory framework
      • 9.4.8.4. Reimbursement scenario
      • 9.4.8.5. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Competitive scenario
      • 9.5.1.3. Regulatory framework
      • 9.5.1.4. Reimbursement scenario
      • 9.5.1.5. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.2. India
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Competitive scenario
      • 9.5.2.3. Regulatory framework
      • 9.5.2.4. Reimbursement scenario
      • 9.5.2.5. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Competitive scenario
      • 9.5.3.3. Regulatory framework
      • 9.5.3.4. Reimbursement scenario
      • 9.5.3.5. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.4. South Korea
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Competitive scenario
      • 9.5.4.3. Regulatory framework
      • 9.5.4.4. Reimbursement scenario
      • 9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.5. Australia
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Competitive scenario
      • 9.5.5.3. Regulatory framework
      • 9.5.5.4. Reimbursement scenario
      • 9.5.5.5. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Competitive scenario
      • 9.5.6.3. Regulatory framework
      • 9.5.6.4. Reimbursement scenario
      • 9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Competitive scenario
      • 9.6.1.3. Regulatory framework
      • 9.6.1.4. Reimbursement scenario
      • 9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Competitive scenario
      • 9.6.2.3. Regulatory framework
      • 9.6.2.4. Reimbursement scenario
      • 9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Competitive scenario
      • 9.7.1.3. Regulatory framework
      • 9.7.1.4. Reimbursement scenario
      • 9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Competitive scenario
      • 9.7.2.3. Regulatory framework
      • 9.7.2.4. Reimbursement scenario
      • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Competitive scenario
      • 9.7.3.3. Regulatory framework
      • 9.7.3.4. Reimbursement scenario
      • 9.7.3.5. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Competitive scenario
      • 9.7.4.3. Regulatory framework
      • 9.7.4.4. Reimbursement scenario
      • 9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
    • 10.2.1. Innovators
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Global Key company market share analysis, 2024
    • 10.3.4. Revital
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Design benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. Hindustan Syringes & Medical Devices Ltd
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Design benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Wuxi Yushou Medical Appliances Co., Ltd
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Design benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Nipro Europe Group Companies
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Design benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Abu Dhabi Medical Devices Company
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Design benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. B. Braun SE
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Design benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. BD
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Design benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Sharps Technology, Inc.
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Design benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Cardinal Health
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Design benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. Vita Needle Company
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Design benchmarking
      • 10.3.13.4. Strategic initiatives
    • 10.3.14. Terumo Europe NV
      • 10.3.14.1. Company overview
      • 10.3.14.2. Financial performance
      • 10.3.14.3. Design benchmarking
      • 10.3.14.4. Strategic initiatives
    • 10.3.15. Taisei Kako Ltd
      • 10.3.15.1. Company overview
      • 10.3.15.2. Financial performance
      • 10.3.15.3. Design benchmarking
      • 10.3.15.4. Strategic initiatives
    • 10.3.16. ulti med Products
      • 10.3.16.1. Company overview
      • 10.3.16.2. Financial performance
      • 10.3.16.3. Design benchmarking
      • 10.3.16.4. Strategic initiatives
    • 10.3.17. Henke Sass Wolf GmbH
      • 10.3.17.1. Company overview
      • 10.3.17.2. Financial performance
      • 10.3.17.3. Design benchmarking
      • 10.3.17.4. Strategic initiatives
    • 10.3.18. ITO CORPORATION
      • 10.3.18.1. Company overview
      • 10.3.18.2. Financial performance
      • 10.3.18.3. Design benchmarking
      • 10.3.18.4. Strategic initiatives
    • 10.3.19. Retractable Technologies, Inc.
      • 10.3.19.1. Company overview
      • 10.3.19.2. Financial performance
      • 10.3.19.3. Design benchmarking
      • 10.3.19.4. Strategic initiatives
    • 10.3.20. kohope.com
      • 10.3.20.1. Company overview
      • 10.3.20.2. Financial performance
      • 10.3.20.3. Design benchmarking
      • 10.3.20.4. Strategic initiatives
    • 10.3.21. Al Shifa Medical Products Co
      • 10.3.21.1. Company overview
      • 10.3.21.2. Financial performance
      • 10.3.21.3. Design benchmarking
      • 10.3.21.4. Strategic initiatives
    • 10.3.22. Liaoning Kangyi Medical Equipment Co., Ltd
      • 10.3.22.1. Company overview
      • 10.3.22.2. Financial performance
      • 10.3.22.3. Design benchmarking
      • 10.3.22.4. Strategic initiatives
    • 10.3.23. CANE SPA
      • 10.3.23.1. Company overview
      • 10.3.23.2. Financial performance
      • 10.3.23.3. Design benchmarking
      • 10.3.23.4. Strategic initiatives
    • 10.3.24. SMB Corporation of India
      • 10.3.24.1. Company overview
      • 10.3.24.2. Financial performance
      • 10.3.24.3. Design benchmarking
      • 10.3.24.4. Strategic initiatives
    • 10.3.25. Lifelong Meditech Private Limited.
      • 10.3.25.1. Company overview
      • 10.3.25.2. Financial performance
      • 10.3.25.3. Design benchmarking
      • 10.3.25.4. Strategic initiatives
    • 10.3.26. OSAKA CHEMICAL Co., Ltd
      • 10.3.26.1. Company overview
      • 10.3.26.2. Financial performance
      • 10.3.26.3. Design benchmarking
      • 10.3.26.4. Strategic initiatives
    • 10.3.27. JMS Co.Ltd
      • 10.3.27.1. Company overview
      • 10.3.27.2. Financial performance
      • 10.3.27.3. Design benchmarking
      • 10.3.27.4. Strategic initiatives
    • 10.3.28. APEX MEDICAL DEVICES
      • 10.3.28.1. Company overview
      • 10.3.28.2. Financial performance
      • 10.3.28.3. Design benchmarking
      • 10.3.28.4. Strategic initiatives
    • 10.3.29. Cartel Health Care Pvt. Ltd
      • 10.3.29.1. Company overview
      • 10.3.29.2. Financial performance
      • 10.3.29.3. Design benchmarking
      • 10.3.29.4. Strategic initiatives
    • 10.3.30. VEM Tooling Co., Ltd. (VEM Thailand Co., Ltd.)
      • 10.3.30.1. Company overview
      • 10.3.30.2. Financial performance
      • 10.3.30.3. Design benchmarking
      • 10.3.30.4. Strategic initiatives
    • 10.3.31. Fresenius Kabi Canada Ltd
      • 10.3.31.1. Company overview
      • 10.3.31.2. Financial performance
      • 10.3.31.3. Design benchmarking
      • 10.3.31.4. Strategic initiatives
    • 10.3.32. ICU Medical, Inc.
      • 10.3.32.1. Company overview
      • 10.3.32.2. Financial performance
      • 10.3.32.3. Design benchmarking
      • 10.3.32.4. Strategic initiatives
  • 10.4. Heat Map Analysis/ Company Market Position Analysis
  • 10.5. Estimated Company Market Share Analysis, 2024
  • 10.6. List of Other Key Market Players